< Back to previous page
Researcher
Diether Lambrechts
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Diether Lambrechts (KU Leuven)
Affiliations
- Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Jan 2017 → Today - Lambrechts Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 2003 → 30 Sep 2005 - Department of Cellular and Molecular Medicine (Department)
Member
From1 Oct 1999 → 30 Sep 2003
Projects
1 - 7 of 7
- EXPANDing Immune Cells and their Tumor Antigens during checkpoint immunotherapyFrom1 Jan 2023 → TodayFunding: HORIZON.1.1 - European Research Council (ERC)
- VIB Grant for Lambrechts Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- CIRCULATING TUMOR DNA AS AN EPIGENETIC BIOMARKER FOR TUMOR RESPONSE’ — ‘INITIATOR’ - ERC POCFrom1 Aug 2020 → 31 Jan 2022Funding: HORIZON.1.1 - European Research Council (ERC)
- RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.’ — ‘RESCUER’From1 Jan 2020 → TodayFunding: Other EU initiatives out of framework
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics (GLIOTRAIN) - Marie Sklodowska-Curie actions (ITN)From1 Sep 2017 → 31 Aug 2021Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Lambrechts Lab_Period:2017-01-01-2021-12-31From1 Jan 2017 → 31 Dec 2021Funding: FRI - Project driven research
Publications
41 - 50 of 230
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes(2022)
Authors: Diether Lambrechts
Pages: 2 - CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.(2022)
Authors: Diether Lambrechts
Pages: 1954 - Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease.(2022)
Authors: Bram Boeckx, Diether Lambrechts, Rekin's Janky
Pages: 814-828 - Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.(2022)
Authors: Diether Lambrechts
Pages: 1533-1544 - The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.(2022)
Authors: Diether Lambrechts
Pages: 10159 - European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.(2022)
Authors: Diether Lambrechts
Pages: 276-287 - Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis.(2022)
Authors: Diether Lambrechts
Pages: 79 - Polygenic risk modeling for prediction of epithelial ovarian cancer risk.(2022)
Authors: Diether Lambrechts, Siel Olbrecht
Pages: 349-362 - Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.(2022)
Authors: Diether Lambrechts
Pages: 3342-3355 - PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.(2022)
Authors: Matteo Rossi, Patricia Altea Manzano, Margherita Demicco, Ginevra Doglioni, Anke Vandekeere, Alejandro Cuadros, Juan Fernandez Garcia, Carla Riera Domingo, Hamza Furkan Alkan, Lindsay Broadfield, et al.
Pages: 747-753
Patents
1 - 10 of 10
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- BIOMARKERS PREDICTING RESPONSE OF BREAST CANCER TO IMMUNOTHERAPY (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- DETECTION OF OVARIAN CANCER IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)